Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer

We aimed to investigate the impact of muscle atrophy and the neutrophil-to-lymphocyte ratio (NLR), a sub-clinical biomarker of inflammation and nutrition, on the prognosis of patients with unresectable advanced gastric cancer. We retrospectively enrolled 109 patients with stage IV gastric cancer (me...

Full description

Bibliographic Details
Main Authors: Kota Shigeto, Takumi Kawaguchi, Shunji Koya, Keisuke Hirota, Toshimitsu Tanaka, Sachiko Nagasu, Masaru Fukahori, Tomoyuki Ushijima, Hiroo Matsuse, Keisuke Miwa, Koji Nagafuji, Takuji Torimura
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/6/1884
_version_ 1797564330577756160
author Kota Shigeto
Takumi Kawaguchi
Shunji Koya
Keisuke Hirota
Toshimitsu Tanaka
Sachiko Nagasu
Masaru Fukahori
Tomoyuki Ushijima
Hiroo Matsuse
Keisuke Miwa
Koji Nagafuji
Takuji Torimura
author_facet Kota Shigeto
Takumi Kawaguchi
Shunji Koya
Keisuke Hirota
Toshimitsu Tanaka
Sachiko Nagasu
Masaru Fukahori
Tomoyuki Ushijima
Hiroo Matsuse
Keisuke Miwa
Koji Nagafuji
Takuji Torimura
author_sort Kota Shigeto
collection DOAJ
description We aimed to investigate the impact of muscle atrophy and the neutrophil-to-lymphocyte ratio (NLR), a sub-clinical biomarker of inflammation and nutrition, on the prognosis of patients with unresectable advanced gastric cancer. We retrospectively enrolled 109 patients with stage IV gastric cancer (median age 69 years; female/male 22%/78%; median observational period 261 days). Independent factors and profiles for overall survival (OS) were determined by Cox regression analysis and decision-tree analysis, respectively. OS was calculated using the Kaplan–Meier method. The prevalence of muscle atrophy was 82.6% and the median NLR was 3.15. In Cox regression analysis, none of factors were identified as an independent factor for survival. The decision-tree analysis revealed that the most favorable prognostic profile was non-muscle atrophy (OS rate 36.8%). The most unfavorable prognostic profile was the combination of muscle atrophy and high NLR (OS rate 19.6%). The OS rate was significantly lower in patients with muscle atrophy and high NLR than in patients with non-muscle atrophy (1-year survival rate 28.5% vs. 54.7%; log-rank test <i>p</i> = 0.0014). In conclusion, “muscle atrophy and high NLR” was a prognostic profile for patients with stage IV gastric cancer. Thus, the assessment of muscle mass, subclinical inflammation, and malnutrition may be important for the management of patients with stage IV gastric cancer.
first_indexed 2024-03-10T18:55:48Z
format Article
id doaj.art-e1ce34a3b38a4dcb80ffc4069b9312ac
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T18:55:48Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-e1ce34a3b38a4dcb80ffc4069b9312ac2023-11-20T04:48:27ZengMDPI AGNutrients2072-66432020-06-01126188410.3390/nu12061884Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric CancerKota Shigeto0Takumi Kawaguchi1Shunji Koya2Keisuke Hirota3Toshimitsu Tanaka4Sachiko Nagasu5Masaru Fukahori6Tomoyuki Ushijima7Hiroo Matsuse8Keisuke Miwa9Koji Nagafuji10Takuji Torimura11Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanDivision of Gastroenterology, Kurume University School of Medicine, Kurume 830-0011, JapanDivision of Rehabilitation, Kurume University Hospital, Kurume 830-0011, JapanDivision of Rehabilitation, Kurume University Hospital, Kurume 830-0011, JapanMultidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanMultidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanMultidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanMultidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanDivision of Rehabilitation, Kurume University Hospital, Kurume 830-0011, JapanMultidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanMultidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume 830-0011, JapanDivision of Gastroenterology, Kurume University School of Medicine, Kurume 830-0011, JapanWe aimed to investigate the impact of muscle atrophy and the neutrophil-to-lymphocyte ratio (NLR), a sub-clinical biomarker of inflammation and nutrition, on the prognosis of patients with unresectable advanced gastric cancer. We retrospectively enrolled 109 patients with stage IV gastric cancer (median age 69 years; female/male 22%/78%; median observational period 261 days). Independent factors and profiles for overall survival (OS) were determined by Cox regression analysis and decision-tree analysis, respectively. OS was calculated using the Kaplan–Meier method. The prevalence of muscle atrophy was 82.6% and the median NLR was 3.15. In Cox regression analysis, none of factors were identified as an independent factor for survival. The decision-tree analysis revealed that the most favorable prognostic profile was non-muscle atrophy (OS rate 36.8%). The most unfavorable prognostic profile was the combination of muscle atrophy and high NLR (OS rate 19.6%). The OS rate was significantly lower in patients with muscle atrophy and high NLR than in patients with non-muscle atrophy (1-year survival rate 28.5% vs. 54.7%; log-rank test <i>p</i> = 0.0014). In conclusion, “muscle atrophy and high NLR” was a prognostic profile for patients with stage IV gastric cancer. Thus, the assessment of muscle mass, subclinical inflammation, and malnutrition may be important for the management of patients with stage IV gastric cancer.https://www.mdpi.com/2072-6643/12/6/1884malnutritionskeletal muscleinflammationstomach cancermortality
spellingShingle Kota Shigeto
Takumi Kawaguchi
Shunji Koya
Keisuke Hirota
Toshimitsu Tanaka
Sachiko Nagasu
Masaru Fukahori
Tomoyuki Ushijima
Hiroo Matsuse
Keisuke Miwa
Koji Nagafuji
Takuji Torimura
Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
Nutrients
malnutrition
skeletal muscle
inflammation
stomach cancer
mortality
title Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
title_full Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
title_fullStr Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
title_full_unstemmed Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
title_short Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
title_sort profiles combining muscle atrophy and neutrophil to lymphocyte ratio are associated with prognosis of patients with stage iv gastric cancer
topic malnutrition
skeletal muscle
inflammation
stomach cancer
mortality
url https://www.mdpi.com/2072-6643/12/6/1884
work_keys_str_mv AT kotashigeto profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT takumikawaguchi profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT shunjikoya profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT keisukehirota profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT toshimitsutanaka profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT sachikonagasu profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT masarufukahori profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT tomoyukiushijima profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT hiroomatsuse profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT keisukemiwa profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT kojinagafuji profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer
AT takujitorimura profilescombiningmuscleatrophyandneutrophiltolymphocyteratioareassociatedwithprognosisofpatientswithstageivgastriccancer